A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 8 251,91 ₴, with a 24-hour trading volume of 7,14B ₴. The asset's market cap is 12,79T ₴, after moving -0.12% in the last day.
Tokenized AstraZeneca PLC is trading at 4 605,21 ₴, with a tokenized market cap of 630,84M ₴ and a 24-hour trading volume of 34,29M ₴. The tokenized asset has moved 8.36% in the past 24 hours.